Manufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.
Thomas Ruggia
Advertisement
President and CEO, Samsara Vision
Articles by Thomas Ruggia
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somnivera
2
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership
3
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
4
The Most Surprising Development in GLP-1s
5